Readmission Risk Assessment Tool (RRAT) for Decreasing 30-Day Readmission Rates in Total Joint Arthroplasty (TJA) and Predicting Readmission.

Background Total joint arthroplasty (TJA) has moved to a value-based care model that emphasizes increased quality and decreased costs. Preoperative patient selection and optimization significantly improve postoperative outcomes, improve quality, and decrease systemic costs. We introduced a readmission risk assessment tool (RRAT) previously verified in the literature at a large, private practice, multispecialty hospital to determine if implementation could improve outcomes and decrease our readmission rates. Methods All patients were administered the RRAT scoring tool prior to surgery. All staff was trained prior by a team consisting of multiple orthopedic surgeons, internal medicine and cardiac specialists, and anesthesiologists. If the score received by the patient was greater or equal to 4, a letter was sent immediately to the operative physician to work on optimization and a list of options for optimization was provided. No patients were expressly denied surgery. Results All 4912 patients from September 2017 to March 2020 were screened using the RRAT tool. A total of 228 patients had an RRAT score greater than 4 and required notification of the index surgeon. The overall readmission rate was 2.61% for all patients. We noted a readmission rate of 2.35% for those with a score of <4, 4.27% for those between 4-6, and 13.64% for those with a readmission rate >6. The odds ratio of those readmitted with an RRAT score >6 was 6.5488 (1.9080-22.4775, 95% CI). The American Society of Anesthesiologists (ASA) score and RRAT score were significantly correlated (Spearman Rho =0.324, P<0.001). Thirty-day readmission rates across the system decreased from 3.7% to 2.61% (p<0.05) when compared to the readmission rate in the year prior to the application of RRAT (September 2016 - August 2017). Conclusion The preoperative RRAT score is significantly correlated with 30-day readmission rates. Notification of the surgeon preoperatively of risk factors with modification options significantly lowered readmission rates in our study. Preoperative optimization leads to a decreased readmission rate and surgeon involvement is paramount to adherence.

Is There a Need for Recovery Room Radiographs Following Uncomplicated Primary Total Knee Arthroplasty?

Introduction Total knee arthroplasty (TKA) is one of the most common orthopedic procedures performed in the United States. Obtaining radiographs in the post-anesthesia care unit (PACU) has been the standard of care at most hospitals. The purpose of this study was to examine the utility and cost-effectiveness of immediate, postoperative radiographs in regards to operative decision-making to prevent complications within 90 days after primary TKA. Methods A retrospective review of 4,830 consecutive patients who underwent cemented or uncemented TKA between January 2016 and June 2019 at a large, regional medical center was performed. International Classification of Diseases, Tenth Revision (ICD-10) codes were used to track any readmissions within 90 days of TKA. If readmission was for a mechanical complication, including fracture, dislocation, or component loosening, PACU radiographs were reviewed for any abnormalities that may have prevented readmission. Results There were 195 readmissions (195 patients), of which 17 were due to mechanical complications. There was no evidence of fracture or abnormality appreciated on any of the reviewed PACU radiographs by either the reading radiologist or the senior authors. Assuming all fractures were noted on immediate, postoperative radiographs, the cost associated with identifying a single fracture in 2,415 patients was $1,072,260. Conclusion Routine radiographs in the recovery room after an uncomplicated primary TKA are not a reliable mechanism for preventing mechanical complications and do not alter patient care.

Is There Value in Pathology Specimens in Routine Total Hip and Knee Arthroplasty?

Background Routine analysis of bone specimens in total joint arthroplasty (TJA) is mandatory at many institutions. The purpose of this study was to determine if mandatory routine TJA specimen analysis alters patient care or if they represent an unnecessary healthcare expenditure. Methods A retrospective review was performed of all primary TJA patients between October 2015 and December 2017 at our institution. Pathology results were reviewed to ascertain the number of concordant, discrepant, and discordant results. A diagnosis was considered concordant if the preoperative and pathologic diagnosis matched, discrepant if the preoperative and pathological diagnosis differed but no change in the patient's plan of care occurred, and discordant if the preoperative and pathologic diagnosis differed and resulted in a change in the patient's plan of care.  Results 3,670 total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures (3,613 patients) met the inclusion criteria and were included in this study. All 3,670 specimens had a concordant diagnosis; there were zero discrepant and zero discordant diagnoses. During the study period, our institution spent $67,246.88 in routine analysis of TJA specimens by a pathologist, with no change in any postoperative patient care plans. Conclusion With bundled payment reimbursement models and hospitals trying to decrease unnecessary expenditures, the present study helps further demonstrate that routine analysis has limited cost-effectiveness due to the low prevalence of alteration in the management of patient care. The decision for pathological analysis should be left at the discretion of the surgeon in order to maximize the cost-efficiency of TJA procedures.